Bioequivalence of a 2.5 mg Linagliptin / 850 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 850 mg Tablets in Healthy Volunteers
Clinical trial NCT02220647 · COMPLETED
Trial details
- NCT number
- NCT02220647
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2010-04-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.